Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell …

H Ai, QS Yin, Q Wang, YW Fu, XD Wei… - Zhonghua xue ye xue za …, 2020 - europepmc.org
Objective: To investigate the efficacy and side effects of anti-CD19 CAR-T cell bridging to
allogeneic hematopoietic stem cell transplantation (allo-HSCT) regimen for refractory B …
被引用次数：2 相关文章

Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell …

H Ai, QS Yin, Q Wang, YW Fu… - Zhonghua xue ye …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective: To investigate the efficacy and side effects of anti-CD19 CAR-T cell bridging to
allogeneic hematopoietic stem cell transplantation (allo-HSCT) regimen for refractory B …